Analyst Consensus ?
ConsensusBuy34 ratings
Bullish2573.5%
Neutral926.5%
Bearish00.0%
FN2 Earnings Intelligence
Labcorp Holdings Inc. complete analyst coverage
Labcorp Holdings Inc. (LH) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$311.54Current
$240Low
$309.68Average
$380High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 14, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Buy | Buy | Maintain | Sep 11, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Sep 11, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Aug 4, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Aug 3, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 31, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 31, 2026 |
| Baird | Outperform | Outperform | Maintain | Jul 13, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 13, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Apr 8, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Oct 17, 2025 |
| Citigroup | Buy | Neutral | Upgrade | Mar 4, 2025 |
| Jefferies | Buy | Buy | Maintain | Feb 6, 2025 |
| HSBC | Buy | Hold | Upgrade | Oct 30, 2024 |
| Deutsche Bank | Hold | Hold | Maintain | Aug 2, 2024 |
| Argus Research | Buy | Hold | Upgrade | Mar 25, 2024 |
| Wells Fargo | Overweight | Overweight | Maintain | Aug 14, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 2, 2023 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jul 13, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | May 21, 2020 |
| Keybanc | Overweight | Overweight | Maintain | Mar 30, 2020 |
| Bank of America | Neutral | Underperform | Upgrade | Jul 16, 2019 |
| Canaccord Genuity | Hold | Hold | Maintain | May 2, 2019 |
| Goldman Sachs | Buy | Conviction Buy | Downgrade | Nov 30, 2018 |
| Argus | Hold | Buy | Downgrade | Oct 30, 2018 |
| JMP Securities | Outperform | Market Outperform | Maintain | Mar 27, 2015 |
| Maxim Group | Buy | Buy | Maintain | Mar 24, 2015 |
| PiperJaffray | Overweight | Neutral | Upgrade | Feb 23, 2015 |
| Raymond James | Outperform | Underperform | Upgrade | Jan 2, 2015 |
| FBR Capital | Market Perform | Market Perform | Maintain | Oct 28, 2014 |
| William Blair | Outperform | Market Perform | Upgrade | Jul 17, 2014 |
| Cantor Fitzgerald | Buy | Buy | Maintain | May 9, 2014 |
| ISI Group | Neutral | Neutral | Maintain | Nov 19, 2013 |
| Craig-Hallum | Buy | Buy | Maintain | Aug 28, 2013 |
| Oppenheimer | Perform | Perform | Maintain | Jan 28, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $311.54. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Kevin Caliendo | $380 | $307.42 | +22.0% | Sep 11, 2026 |
| Barclays | Analyst unavailable | $330 | $306.96 | +5.9% | Sep 11, 2026 |
| Mizuho Securities | Ann Hynes | $355 | $319.17 | +14.0% | Aug 10, 2026 |
| Morgan Stanley | Analyst unavailable | $338 | $308.64 | +8.5% | Jul 31, 2026 |
| Deutsche Bank | Analyst unavailable | $306 | $308.7 | -1.8% | Jul 31, 2026 |
| Robert W. Baird | Analyst unavailable | $352 | $315.53 | +13.0% | Jul 31, 2026 |
| Barclays | Analyst unavailable | $320 | $315.82 | +2.7% | Jul 30, 2026 |
| Robert W. Baird | Eric Coldwell | $334 | $255.97 | +7.2% | May 1, 2026 |
| Evercore ISI | Analyst unavailable | $300 | $274.72 | -3.7% | Apr 8, 2026 |
| Piper Sandler | David Westenberg | $300 | $285.3 | -3.7% | Feb 24, 2026 |
| Robert W. Baird | Analyst unavailable | $326 | $276.67 | +4.6% | Feb 18, 2026 |
| Robert W. Baird | Analyst unavailable | $313 | $259.18 | +0.5% | Jan 14, 2026 |
| UBS | Kevin Caliendo | $320 | $253.74 | +2.7% | Oct 29, 2025 |
| Robert W. Baird | Analyst unavailable | $304 | $259.69 | -2.4% | Oct 29, 2025 |
| Leerink Partners | Michael Cherny | $342 | $261.62 | +9.8% | Oct 28, 2025 |
| UBS | Analyst unavailable | $325 | $285.93 | +4.3% | Oct 17, 2025 |
| Mizuho Securities | Ann Hynes | $320 | $283.71 | +2.7% | Oct 17, 2025 |
| Truist Financial | Analyst unavailable | $320 | $278.42 | +2.7% | Oct 14, 2025 |
| Evercore ISI | Analyst unavailable | $305 | $279.44 | -2.1% | Oct 3, 2025 |
| Barclays | Analyst unavailable | $290 | $279.06 | -6.9% | Oct 2, 2025 |
| Robert W. Baird | Analyst unavailable | $311 | $276.11 | -0.2% | Aug 25, 2025 |
| UBS | Kevin Caliendo | $305 | $264.96 | -2.1% | Jul 25, 2025 |
| Barclays | Analyst unavailable | $275 | $258.7 | -11.7% | Jun 25, 2025 |
| Barclays | Luke Sergott | $271 | $247.86 | -13.0% | Feb 3, 2025 |
| Evercore ISI | Elizabeth Anderson | $240 | $224.72 | -23.0% | Sep 24, 2024 |
| Jefferies | Brian Tanquilut | $265 | $222.22 | -14.9% | Sep 23, 2024 |
| Bank of America Securities | Michael Ryskin | $260 | $236 | -16.5% | Aug 5, 2024 |
| Barclays | Stephanie Davis | $249 | $235.67 | -20.1% | Aug 2, 2024 |
| Argus Research | David Toung | $250 | $212.5 | -19.8% | Mar 25, 2024 |
| Morgan Stanley | Analyst unavailable | $303 | $241.42 | -2.7% | Jan 6, 2023 |
| Credit Suisse | Analyst unavailable | $305 | $238 | -2.1% | Nov 23, 2022 |
| Mizuho Securities | Analyst unavailable | $296 | $254.72 | -5.0% | Jul 29, 2022 |
| Deutsche Bank | Analyst unavailable | $265 | $245.45 | -14.9% | May 3, 2022 |
| Credit Suisse | Analyst unavailable | $312 | $240.28 | +0.1% | May 2, 2022 |
| Wells Fargo | Analyst unavailable | $315 | $266.12 | +1.1% | Apr 25, 2022 |
| Bank of America Securities | Derik de Bruin | $370 | $276.26 | +18.8% | Feb 11, 2022 |
| Deutsche Bank | Pito Chickering | $294 | $270.08 | -5.6% | Jan 28, 2022 |
| Truist Financial | David S Macdonald | $350 | $296.15 | +12.3% | Jul 30, 2021 |
| Argus Research | Jasper Hellweg | $295 | $269.61 | -5.3% | May 20, 2021 |
Track every rating change on LH the moment it posts. Free to start.
Start free